Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-23 5:08 pm Sale | 2025-06-18 | 13D | BiomX Inc. PHGE | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 276,150 1.000% | -1,511,615 (-84.55%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Nantahala Capital Management, LLC | 2,494,197 9.990% | 700,056 (+39.02%) | Filing History |
| 2025-05-15 4:29 pm Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Alyeska Investment Group, L.P. | 2,316,076 9.270% | 2,316,076 (New Position) | Filing History |
| 2025-05-15 4:05 pm Purchase | 2025-04-21 | 13G | BiomX Inc. PHGE | Rodney Hodges | 1,970,403 7.600% | 1,970,403 (New Position) | Filing History |
| 2025-05-08 07:39 am Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Orin Hirschman | 1,566,944 6.300% | 1,566,944 (New Position) | Filing History |
| 2025-03-04 5:34 pm Sale | 2025-02-27 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 2,494,110 9.990% | -1,600,448 (-39.09%) | Filing History |
| 2025-03-03 7:04 pm Purchase | 2025-02-27 | 13D | BiomX Inc. PHGE | James E. Flynn | 15,558,445 9.990% | 0 (+0.00%) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 4,094,558 19.990% | 3,161,500 (+338.83%) | Filing History |
| 2024-11-13 5:30 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Nantahala Capital Management, LLC | 1,794,141 9.990% | 1,794,141 (New Position) | Filing History |
| 2024-11-13 5:14 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | AMR Action Fund L.P. | 876,888 4.900% | 876,888 (New Position) | Filing History |
| 2024-11-04 4:05 pm Purchase | 2024-09-30 | 13G | BiomX Inc. PHGE | Burbank John Howard III | 510,205 2.900% | 510,205 (New Position) | Filing History |
| 2024-10-28 4:01 pm Purchase | 2024-09-30 | 13G | BIOMX INC UNIT 1 COM & 1 WT EX PHGEU | Rodney Hodges | 560,267 3.100% | 560,267 (New Position) | Filing History |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | BiomX Inc. PHGE | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 1,787,765 9.990% | 529,983 (+42.14%) | Filing History |
| 2024-07-11 6:47 pm Purchase | 2024-07-09 | 13D | BiomX Inc. PHGE | James E. Flynn | 15,558,445 9.990% | 14,947,435 (+2446.35%) | Filing History |
| 2024-05-30 7:26 pm Unchanged | 2024-05-30 | 13D | BiomX Inc. PHGE | James E. Flynn | 611,010 8.750% | 0 (Unchanged) | Filing History |
| 2024-03-26 4:30 pm Purchase | 2024-03-26 | 13G | BiomX Inc. PHGE | Cystic Fibrosis Foundation | 933,058 15.600% | 477,827 (+104.96%) | Filing History |
| 2024-03-25 3:35 pm Purchase | 2024-03-15 | 13G | BiomX Inc. PHGE | AMR Action Fund L.P. | 305,487 5.500% | 305,487 (New Position) | Filing History |
| 2024-03-22 5:44 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | James E. Flynn | 611,010 11.060% | 611,010 (New Position) | Filing History |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | BiomX Inc. PHGE | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 1,257,782 19.900% | 797,601 (+173.32%) | Filing History |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | BiomX Inc. PHGE | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 460,181 9.900% | 4,832 (+1.06%) | Filing History |